PLK1 and neoplasm: In mice bearing MDA-MB-435 s.c. xenografts, the micelleplex carrying both Plk1 siRNA and paclitaxel was shown to simultaneous deliver the two agents at the designated ratio to the same tumor cells and synergistically suppress tumor growth, which was significantly more potent than Taxol®.